These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 33686850)

  • 1. HIV-1 Integrase Inhibitors with Modifications That Affect Their Potencies against Drug Resistant Integrase Mutants.
    Smith SJ; Zhao XZ; Passos DO; Pye VE; Cherepanov P; Lyumkis D; Burke TR; Hughes SH
    ACS Infect Dis; 2021 Jun; 7(6):1469-1482. PubMed ID: 33686850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacies of Cabotegravir and Bictegravir against drug-resistant HIV-1 integrase mutants.
    Smith SJ; Zhao XZ; Burke TR; Hughes SH
    Retrovirology; 2018 May; 15(1):37. PubMed ID: 29769116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 Integrase Inhibitors That Are Active against Drug-Resistant Integrase Mutants.
    Smith SJ; Zhao XZ; Passos DO; Lyumkis D; Burke TR; Hughes SH
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32601157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrase Strand Transfer Inhibitors Are Effective Anti-HIV Drugs.
    Smith SJ; Zhao XZ; Passos DO; Lyumkis D; Burke TR; Hughes SH
    Viruses; 2021 Jan; 13(2):. PubMed ID: 33572956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV-1 Integrase Inhibitors That Are Broadly Effective against Drug-Resistant Mutants.
    Smith SJ; Zhao XZ; Burke TR; Hughes SH
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. INSTIs and NNRTIs Potently Inhibit HIV-1 Polypurine Tract Mutants in a Single Round Infection Assay.
    Smith SJ; Ferris A; Zhao X; Pauly G; Schneider JP; Burke TR; Hughes SH
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-Guided Optimization of HIV Integrase Strand Transfer Inhibitors.
    Zhao XZ; Smith SJ; Maskell DP; Métifiot M; Pye VE; Fesen K; Marchand C; Pommier Y; Cherepanov P; Hughes SH; Burke TR
    J Med Chem; 2017 Sep; 60(17):7315-7332. PubMed ID: 28737946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Combination of the R263K and T66I Resistance Substitutions in HIV-1 Integrase Is Incompatible with High-Level Viral Replication and the Development of High-Level Drug Resistance.
    Liang J; Mesplède T; Oliveira M; Anstett K; Wainberg MA
    J Virol; 2015 Nov; 89(22):11269-74. PubMed ID: 26311878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A computational overview of integrase strand transfer inhibitors (INSTIs) against emerging and evolving drug-resistant HIV-1 integrase mutants.
    Sayyed SK; Quraishi M; Jobby R; Rameshkumar N; Kayalvizhi N; Krishnan M; Sonawane T
    Arch Microbiol; 2023 Mar; 205(4):142. PubMed ID: 36966200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral Activity of Bictegravir and Cabotegravir against Integrase Inhibitor-Resistant SIVmac239 and HIV-1.
    Hassounah SA; Alikhani A; Oliveira M; Bharaj S; Ibanescu RI; Osman N; Xu HT; Brenner BG; Mesplède T; Wainberg MA
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4-amino-1-hydroxy-2-oxo-1,8-naphthyridine-containing compounds having high potency against raltegravir-resistant integrase mutants of HIV-1.
    Zhao XZ; Smith SJ; Métifiot M; Marchand C; Boyer PL; Pommier Y; Hughes SH; Burke TR
    J Med Chem; 2014 Jun; 57(12):5190-202. PubMed ID: 24901667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of HIV-1 integrase resistance mutations when introduced into SIVmac239 on susceptibility to integrase strand transfer inhibitors.
    Hassounah SA; Mesplède T; Quashie PK; Oliveira M; Sandstrom PA; Wainberg MA
    J Virol; 2014 Sep; 88(17):9683-92. PubMed ID: 24920794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral activity of HIV-1 integrase strand-transfer inhibitors against mutants with integrase resistance-associated mutations and their frequency in treatment-naïve individuals.
    Margot NA; Ram RR; White KL; Abram ME; Callebaut C
    J Med Virol; 2019 Dec; 91(12):2188-2194. PubMed ID: 31389026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro analysis of the replicative capacity and phenotypic susceptibility to integrase inhibitors of HIV-2 mutants with integrase insertions.
    Le Hingrat Q; Collin G; Damond F; Peytavin G; Lebourgeois S; Ghosn J; Bachelard A; Ferré VM; Matheron S; Descamps D; Charpentier C
    J Antimicrob Chemother; 2022 Feb; 77(2):409-412. PubMed ID: 34741606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered viral fitness and drug susceptibility in HIV-1 carrying mutations that confer resistance to nonnucleoside reverse transcriptase and integrase strand transfer inhibitors.
    Hu Z; Kuritzkes DR
    J Virol; 2014 Aug; 88(16):9268-76. PubMed ID: 24899199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 Integrase Strand Transfer Inhibitors with Reduced Susceptibility to Drug Resistant Mutant Integrases.
    Zhao XZ; Smith SJ; Maskell DP; Metifiot M; Pye VE; Fesen K; Marchand C; Pommier Y; Cherepanov P; Hughes SH; Burke TR
    ACS Chem Biol; 2016 Apr; 11(4):1074-81. PubMed ID: 26808478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary resistance against integrase strand transfer inhibitors in integrase strand transfer inhibitor-naive patients failing first- and second-line ART in Tanzania.
    Henerico S; Lyimo E; Makubi AN; Magesa D; Desderius B; Mueller A; Changalucha J; Kalluvya SE; Van Zyl G; Preiser W; Mshana SE; Kasang C
    J Antimicrob Chemother; 2022 Oct; 77(11):3138-3143. PubMed ID: 36101479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selectivity for strand-transfer over 3'-processing and susceptibility to clinical resistance of HIV-1 integrase inhibitors are driven by key enzyme-DNA interactions in the active site.
    Métifiot M; Johnson BC; Kiselev E; Marler L; Zhao XZ; Burke TR; Marchand C; Hughes SH; Pommier Y
    Nucleic Acids Res; 2016 Aug; 44(14):6896-906. PubMed ID: 27369381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural polymorphism S119R of HIV-1 integrase enhances primary INSTI resistance.
    Hachiya A; Ode H; Matsuda M; Kito Y; Shigemi U; Matsuoka K; Imamura J; Yokomaku Y; Iwatani Y; Sugiura W
    Antiviral Res; 2015 Jul; 119():84-8. PubMed ID: 25956162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations Located outside the Integrase Gene Can Confer Resistance to HIV-1 Integrase Strand Transfer Inhibitors.
    Malet I; Subra F; Charpentier C; Collin G; Descamps D; Calvez V; Marcelin AG; Delelis O
    mBio; 2017 Sep; 8(5):. PubMed ID: 28951475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.